NMDA receptors and fear extinction: Implications for cognitive behavioral therapy

Dialogues in Clinical Neuroscience

Volumn 13, Issue 4, 2011, Pages 463-474

  Davis, Michael ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Amygdala; D cycloserine; Learning; Memory; Psychotherapy

Indexed keywords

CYCLOSERINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMYGDALOID NUCLEUS; ANTICIPATION; ARTICLE; COGNITIVE THERAPY; CONDITIONING; DRUG TOLERANCE; FEAR; FEAR EXTINCTION; HUMAN; HUMIDITY; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; PREFRONTAL CORTEX; PSYCHOTHERAPY; SENSORY STIMULATION; SOCIAL PHOBIA; STIMULUS; TREATMENT CONTRAINDICATION; ANIMAL; ANXIETY DISORDER; DRUG EFFECT; DRUG POTENTIATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REINFORCEMENT; REVIEW;

AMYGDALA; ANIMALS; ANXIETY DISORDERS; COGNITIVE THERAPY; CYCLOSERINE; EXTINCTION, PSYCHOLOGICAL; FEAR; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84857660543     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: 10.31887/dcns.2011.13.4/mdavis     Document Type: Article

References (113)

1. Myers KM, Davis M. Behavioral and neural analysis of extinction: a review. Neuron. 2002;36:567-584.
2. Delamater AR. Experimental extinction in Pavlovian conditioning: behavioural and neuroscience perspectives. Q J Exp Psychol B. 2004;57:97-132.
3. Dubin WJ, Levis DJ. Generalization of extinction gradients: a systematic analysis. J Exp Psychol. 1974;100:403-412.
4. Rescorla RA, Heth CD. Reinstatement of fear to an extinguished conditioned stimulus. J Exp Psychol Anim Behav Process. 1975;1:88-96.
5. Bouton ME, Bolles RC. Role of conditioned contextual stimuli in reinstatement of extinguished fear. J Exp Psychol Anim Behav Process. 1979;5:368-378.
6. Bouton ME, King DA. Contextual control of conditioned fear: tests for the associative value of the context. J Exp Psychol Anim Behav Process. 1983;9:248-256.
7. Hendry JS. Summation of undetected excitation following exinction of the CER. Animal Learn Behav. 1982;10:476-482.
8. Bouton ME, Bolles RC. Contextual control of the extinction of conditioned fear. Learn Motivation. 1979;10:455-466.
9. Harris JA, Jones ML, Bailey GK, Westbrook RF. Contextual control over conditioned responding in an extinction paradigm. J Exp Psychol Anim Behav Process. 2000;26:174-185.
10. Quirk GJ. Memory for extinction of conditioned fear is long-lasting and persists following spontaneous recovery. Learn Mem. 2002;9:402-407.
11. Bouton ME. Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull. 1993;114:80-99.
12. Konorski J. Conditioned Reflexes and Neuronal Organization. London, UK: Cambridge University Press; 1948.
13. Wagner AR. SOP: a model of automatic memory processing in animal behavior. In: Spear NE, Miller RR, eds. Information Processing in Animals: Memory Mechanisms. Hillsdale, NJ: Lawrence Erlbaum Associates; 1981:5-47.
14. Malinow R, Malenka RC. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci. 2002;25:103-126.
15. Zhou Q, Poo MM. Reversal and consolidation of activity-induced synaptic modifications. Trends Neurosci. 2004;27:378-383.
16. Lin CH, Yeh SH, Lu HY, Gean PW. The similarities and diversities of signal pathways leading to consolidation of conditioning and consolidation of extinction of fear memory. J Neurosci. 2003;23:8310-8317.
17. Lin CH, Lee CC, Huang YC, Wang SJ, Gean PW. Activation of group II metabotropic glutamate receptors induces depotentiation in amygdala slices and reduces fear-potentiated startle in rats. Learn Mem. 2005;12:130-137.
18. Myers KM, Ressler KJ, Davis M. Different mechanisms of fear extinction dependent on length of time since fear acquisition. Learn Mem. 2006;13:216-213
19. Cain CK, Godsil BP, Jami S, Barad M. The L-type calcium channel blocker nifedipine impairs extinction, but not reduced contingency effects, in mice. Learn Mem. 2005;12:277-284.
20. Monfils MH, Cowansage KK, Klann E, LeDoux JE. Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories. Science. 2009;324:951-955.
21. Schiller D, Monfils MH, Raio CM, Johnson DC, Ledoux JE, Phelps EA. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature. 2010;463:49-53.
22. Miserendino MJ, Sananes CB, Melia KR, Davis M. Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature. 1990;345:716-718.
23. Falls WA, Miserendino MJ, Davis M. Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci. 1992;12:854-863.
24. Baker JD, Azorlosa JL. The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning. Behav Neurosci. 1996;110:618-620.
25. Dalton GL, Wang YT, Floresco SB, Phillips AG. Disruption of AMPA receptor endocytosis impairs the extinction, but not acquisition of learned fear. Neuropsychopharmacology. 2008;33:2416-2426.
26. Santini E, Muller RU, Quirk GJ. Consolidation of extinction learning involves transfer from NMDA- independent to NMDA-dependent memory. J Neurosci. 2001;21:9009-9017.
27. Sotres-Bayon F, Diaz-Mataix L, Bush DE, LeDoux JE. Dissociable roles for the ventromedial prefrontal cortex and amygdala in fear extinction: NR2B contribution. Cereb Cortex. 2009;19:474-482.
28. Sotres-Bayon F, Bush DE, LeDoux JE. Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala. Neuropsychopharmacology. 2007;32:1929-1940.
29. Burgos-Robles A, Vidal-Gonzalez I, Santini E, Quirk GJ. Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron. 2007;53:871-880.
30. Laurent V, Marchand AR, Westbrook RF. The basolateral amygdala is necessary for learning but not relearning extinction of context conditioned fear. Learn Mem. 2008;15:304-314.
31. Laurent V, Westbrook RF. Distinct contributions of the basolateral amygdala and the medial prefrontal cortex to learning and relearning extinction of context conditioned fear. Learn Mem. 2008;15:657-666.
32. Santini E, Ge H, Ren K, Pena de Ortiz S, Quirk GJ. Consolidation of fear extinction requires protein synthesis in the medial prefrontal cortex. J Neurosci. 2004;24:5704-5710.
33. Lee H, Kim JJ. Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats. J Neurosci. 1998;18:8444-8454.
34. Szapiro G, Vianna MR, McGaugh JL, Medina JH, Izquierdo I. The role of NMDA glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of conditioned fear. Hippocampus. 2003;13:53-58.
35. Cox J, Westbrook RF. The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesia responses in the rat. Q J Exp Psychol. 1994;47B:187-210.
36. Berretta S, Pantazopoulos H, Caldera M, Pantazopoulos P, Pare D. Infralimbic cortex activation increases c-Fos expression in intercalated neurons of the amygdala. Neuroscience. 2005;132:943-953.
37. Rosenkranz JA, Grace AA. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci. 2001;21:4090-4103.
38. Rosenkranz JA, Grace AA. Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci. 2002;22:324-337.
39. Rosenkranz JA, Moore H, Grace AA. The prefrontal cortex regulates lateral amygdala neuronal plasticity and responses to previously conditioned stimuli. J Neurosci. 2003;23:11054-11064.
40. Quirk GJ, Likhtik E, Pelletier JG, Pare D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci. 2003;23:8800-8807.
41. Quirk GJ, Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology. 2008;33:56-72.
42. Garcia R, Chang CH, Maren S. Electrolytic lesions of the medial prefrontal cortex do not interfere with long-term memory of extinction of conditioned fear. Learn Mem. 2006;13:14-17.
43. Gewirtz JC, Falls WA, Davis M. Normal conditioned inhibition and extinction of freezing and fear potentiated startle following electrolytic lesions of medial prefrontal cortex. Behav Neurosci. 1997;111:712-726.
44. Quirk GJ, Russo GK, Barron JL, Lebron K. The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci. 2000;20:6225-6231.
45. Sierra-Mercado D, Padilla-Coreano N, Quirk GJ. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology. 2011;36:529-538.
46. Hsu E, Packard MG. Medial prefrontal cortex infusions of bupivacaine or AP-5 block extinction of amphetamine conditioned place preference. Neurobiol Learn Mem. 2008;89:504-512.
47. Milad MR, Quirk GJ. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature. 2002;420:70-74.
48. Milad MR, Vidal-Gonzalez I, Quirk GJ. Electrical stimulation of medial prefrontal cortex reduces conditioned fear in a temporally specific manner. Behav Neurosci. 2004;118:389-394.
49. Laurent V, Westbrook RF. Inactivation of the infralimbic but not the prelimbic cortex impairs consolidation and retrieval of fear extinction. Learn Mem. 2009;16:520-529.
50. Chan WY, McNally GP. Conditioned stimulus familiarity determines effects of MK-801 on fear extinction. Behav Neurosci. 2009;123:303-314.
51. Myers KM, Carlezon WA Jr, Davis M. Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology. 2011;36:910.
52. Walker DL, Ressler KJ, Lu K-T, Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of Dcycloserine as assessed with fear-potentiated startle in rats. J Neurosci. 2002;22:2343-2351.
53. Bouton ME, Vurbic D, Woods AM. D-cycloserine facilitates context-specific fear extinction learning. Neurobiol Learn Mem. 2008;90:504-510.
54. Ledgerwood L, Richardson R, Cranney J. Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci. 2003;117:341-349.
55. Ledgerwood L, Richardson R, Cranney J. D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry. 2005;57:841-847.
56. Lee JL, Milton AL, Everitt BJ. Reconsolidation and extinction of conditioned fear: inhibition and potentiation. J Neurosci. 2006;26:10051-10056.
57. Mao SC, Lin HC, Gean PW. Augmentation of fear extinction by Dcycloserine is blocked by proteasome inhibitors. Neuropsychopharmacology. 2008;33:3085-3095.
58. Walker DL, Davis M. Light enhanced startle: further pharmacological and behavioral evaluation. Psychopharmacology. 2002;159:304-310.
59. Weber M, Hart J, Richardson R. Effects of D-cycloserine on extinction of learned fear to an olfactory cue. Neurobiol Learn Mem. 2007;87:476- 482.
60. Woods A, Bouton M. D-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response. Behav Neurosci. 2006;120:1159-1162.
61. Yang YL, Lu KT. Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala. Neuroscience. 2005;134:247-260.
62. Mao SC, Hsiao YH, Gean PW. Extinction training in conjunction with a partial agonist of the glycine site on the NMDA receptor erases memory trace. J Neurosci. 2006;26:8892-8899.
63. Chang CH, Maren S. Medial prefrontal cortex activation facilitates reextinction of fear in rats. Learn Mem. 2011;18:221-225.
64. Matsumoto M, Togashi H, Konno K, et al. Early postnatal stress alters the extinction of context-dependent conditioned fear in adult rats. Pharmacol Biochem Behav. 2008; 89:247-252.
65. Nic Dhonnchadha BA, Szalay JJ, Achat-Mendes C, et al. D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning. Neuropsychopharmacology. 2010;35:357-367.
66. Yamamoto S, Morinobu S, Fuchikami M, Kurata A, Kozuru T, Yamawaki S. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. Neuropsychopharmacology. 2008;33:2108-2116.
67. Bertotto ME, Bustos SG, Molina VA, Martijena ID. Influence of ethanol withdrawal on fear memory: effect of d-cycloserine. Neuroscience. 2006;142:979-990.
68. Silvestri AJ, Root DH. Effects of REM deprivation and an NMDA agonist on the extinction of conditioned fear. Physiol Behav. 2008;93:274-281.
69. Yu H, Wang Y, Pattwell S, et al. Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory. J Neurosci. 2009;29:4056-4064.
70. McCallum J, Kim JH, Richardson R. Impaired extinction retention in adolescent rats: effects of D-cycloserine. Neuropsychopharmacology. 2010;35:2134-2142.
71. Yang YL, Chao PK, Ro LS, Wo YY, Lu KT. Glutamate NMDA receptors within the amygdala participate in the modulatory effect of glucocorticoids on extinction of conditioned fear in rats. Neuropsychopharmacology. 2007;32:1042-1051.
72. Judo C, Matsumoto M, Yamazaki D, et al. Early stress exposure impairs synaptic potentiation in the rat medial prefrontal cortex underlying contextual fear extinction. Neuroscience. 2010;169:1705-1714.
73. Grillon C. D-cycloserine facilitation of fear extinction and exposurebased therapy might rely on lower-level, automatic mechanisms. Biol Psychiatry. 2009;66:636-641.
74. Ressler KJ, Rothbaum BO, Tannenbaum L, et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry. 2004;61:1136-1144.
75. Rothbaum BO, Hodges LF, Kooper R, Opdyke D, Williford JS, North M. Effectiveness of computer-generated (virtual reality) graded exposure in the treatment of acrophobia. Am J Psychiatry. 1995;152:626-628.
76. Guastella AJ, Richardson R, Lovibond PF, et al. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry. 2008;63:544-549.
77. Hofmann SG, Meuret AE, Smits JA, et al. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006;63:298-304.
78. Kushner MG, Kim SW, Donahue C, et al. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry. 2007;62:835-838
79. Wilhelm S, Buhlmann U, Tolin DF, et al. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry. 2008;165:335-341; quiz 409.
80. Otto MW, Tolin DF, Simon NM, et al. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry. 2010;67:365-370.
81. Storch EA, Merlo LJ, Bengtson M, et al. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2007;22:230-237.
82. Guastella AJ, Dadds MR, Lovibond PF, Mitchell P, Richardson R. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. J Psychiatr Res. 2007;41:466-471.
83. Langton JM, Richardson R. D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions. Neuropsychopharmacology. 2008;33:3096-3102.
84. Werner-Seidler A, Richardson R. Effects of D-cycloserine on extinction: consequences of prior exposure to imipramine. Biol Psychiatry. 2007;10:1195-1197.
85. Parnas AS, Weber M, Richardson R. Effects of multiple exposures to dcycloserine on extinction of conditioned fear in rats. Neurobiol Learn Mem. 2005;83:224-231.
86. Kalisch R, Holt B, Petrovic P, et al. The NMDA agonist D-cycloserine facilitates fear memory consolidation in humans. Cereb Cortex. 2009;19:187-196.
87. Nageswara Rao K, Eidus L, Evans C, et al. Deterioration of cycloserine in the tropics. World Health Organization. 1968;39:781-789.
88. Monahan JB, Handelmann GE, Hood WF, Cordi AA. D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behav. 1989;34:649-653.
89. Land C, Riccio DC. d-Cycloserine: effects on long-term retention of a conditioned response and on memory for contextual attributes. Neurobiol Learn Mem. 1999;72:158-168.
90. Steele RJ, Dermon CR, Stewart MG. D-cycloserine causes transient enhancement of memory for a weak aversive stimulus in day-old chicks (Gallus domesticus). Neurobiol Learn Mem. 1996;66:236-240.
91. Flood JF, Morley JE, Lanthorn TH. Effect on memory processing by Dcycloserine, an agonist of the NMDA/glycine receptor. Eur J Pharmacol. 1992;221:249-254.
92. Dubrovina NI, Zinovyev DR, Zinovyeva DV. N-methyl-D-aspartate receptors and amnesia in mice with depression-like state. Bull Exp Biol Med. 2007;144:647-649.
93. Quartermain D, Mower J, Rafferty MF, Herting RL, Lanthorn TH. Acute but not chronic activation of the NMDA-coupled glycine receptor with Dcycloserine facilitates learning and retention. Eur J Pharmacol. 1994;257:7-12.
94. Assini FL, Duzzioni M, Takahashi RN. Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation. Behav Brain Res. 2009;204:206-211.
95. Land CL, Riccio DC. D-Cycloserine, a positive modulator of the NMDA receptor enhances acquisition of a conditioned taste aversion. Psychobiology. 1997; 25:210-216.
96. Nunnink M, Davenport RA, Ortega B, Houpt TA. D-Cycloserine enhances conditioned taste aversion learning in rats. Pharmacol Biochem Behav. 2007;87:321-330.
97. Matsuoka N, Aigner TG. D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys. J Pharmacol Exp Ther. 1996;278:891-897
98. Thompson LT, Moskal Jr, Disterhoftt JF. Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserine. Nature. 1992;359:638-641.
99. Baxter MG, Lanthorn TH, Frick KM, Golski S, Wan RQ, Olton DS. Dcycloserine, a novel cognitive enhancer, improves spatial memory in aged rats. Neurobiol Aging. 1994;15:207-213.
100. Thompson LT, Disterhoft JF. Age- and dose-dependent facilitation of associative eyeblink conditioning by D-cycloserine in rabbits. Behav Neurosci. 1997;111:1303-1312.
101. Fishkin RJ, Ince ES, Carlezon WA Jr, Dunn RW. D-cycloserine attenuates scopolamine-induced learning and memory deficits in rats. Behav Neural Biol. 1993;59:150-157.
102. Ohno M, Watanabe S. D-cycloserine, a glycine site agonist, reverses working memory failure by hippocampal muscarinic receptor blockade in rats. Eur J Pharmacol. 1996;318:267-271.
103. Zajaczkowski W, Danysz W. Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions. Pharmacol Biochem Behav. 1997;56:21-29.
104. Temple MD, Hamm RJ. Chronic, post-injury administration of Dcycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury. Brain Res. 1996;741:246-251.
105. Schuster GM, Schmidt WJ. D-cycloserine reverses the working memory impairment of hippocampal-lesioned rats in a spatial learning task. Eur J Pharmacol. 1992;224:97-98.
106. Maurice T, Lockhart BP, Su TP, Privat A. Reversion of beta 25-35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists. Brain Res. 1996;731:249-253.
107. Wlaz P, Rolinski Z, Czuczwar SJ. Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice. Epilepsia. 1996;37:610-617.
108. Otto MW, Basden SL, McHugh RK, et al. Effects of D-cycloserine administration on weekly nonemotional memory tasks in healthy participants. Psychother Psychosom. 2009;78:49-54.
109. D'Souza DC, Gil R, Cassello K, et al. IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans. Biol Psychiatry. 2000;47:450-462.
110. Kuriyama K, Honma M, Koyama S, Kim Y. D-cycloserine facilitates procedural learning but not declarative learning in healthy humans: a randomized controlled trial of the effect of d-cycloserine and valproic acid on overnight properties in the performance of non-emotional memory tasks. Neurobiol Learn Mem. 2011;95:505-509.
111. Onur OA, Schlaepfer TE, Kukolja J, et al. The N-methyl-D-aspartate receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans. Biol Psychiatry. 2010;67:1205-1211.
112. Goff DC, Cather C, Gottlieb JD, et al. Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study. Schizophr Res. 2008;106:320-327.
113. Davis M, Ressler K, Rothbaum BO, Richardson R. Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry. 2006;60:369-375.